[PDF][PDF] Role of Src family kinases in acquired resistance to EGFR therapies in cancer
JL Boerner - Cancer Biology & Therapy, 2009 - Taylor & Francis
JL Boerner
Cancer Biology & Therapy, 2009•Taylor & FrancisRole of Src family kinases in acquired resistance to EGFR therapies in cancer Page 1 [Cancer
Biology & Therapy 8:8, 704-706; 15 April 2009]; ©2009 Landes Bioscience 704 Cancer Biology
& Therapy 2009; Vol. 8 Issue 8 The epidermal growth factor receptor (EGFR) is overexpressed
in almost every solid tumor type, including breast, prostate, nonsmall cell lung cancer, head
and neck, gastric, colorectal, esophageal, pancreatic, bladder, renal and ovarian cancers.The
mechanism and significance of this expression of the EGFR has been intensely scrutinized …
Biology & Therapy 8:8, 704-706; 15 April 2009]; ©2009 Landes Bioscience 704 Cancer Biology
& Therapy 2009; Vol. 8 Issue 8 The epidermal growth factor receptor (EGFR) is overexpressed
in almost every solid tumor type, including breast, prostate, nonsmall cell lung cancer, head
and neck, gastric, colorectal, esophageal, pancreatic, bladder, renal and ovarian cancers.The
mechanism and significance of this expression of the EGFR has been intensely scrutinized …
Commentary to:
Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab
Deric L. Wheeler, Mar Iida, Tim J. Kruser, Meghan M. Nechrebecki, Emily F. Dunn, Eric A. Armstrong, Shyhmin Huang, Paul M. Harar
Taylor & Francis Online